US 10030061
Hepcidin analogues and uses thereof
granted A61KA61K38/00A61P
Quick answer
US patent 10030061 (Hepcidin analogues and uses thereof) held by Protagonist Therapeutics, Inc. expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Protagonist Therapeutics, Inc.
- Grant date
- Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K38/00, A61P, A61P3/00, A61P3/12